Change in the Roche Board of Directors

Core Points - Dr. Claudia Süssmuth Dyckerhoff will not seek re-election to Roche's Board of Directors in 2026 and will be nominated for another healthcare company board [1] - Dr. Süssmuth Dyckerhoff has been a board member since March 2016 and has made significant contributions to Roche's success, particularly in understanding international market dynamics [2] Company Overview - Roche, founded in 1896 in Basel, Switzerland, is the world's largest biotechnology company and a leader in in-vitro diagnostics [2] - The company focuses on developing innovative medicines and diagnostics to improve global health and is a pioneer in personalized healthcare [2][3] - Roche is committed to sustainability and aims to achieve net zero by 2045 through initiatives like the Science Based Targets initiative [3]